InvestorsObserver
×
News Home

Should You Add FSD Pharma Inc (HUGE) Stock to Your Portfolio Wednesday?

Wednesday, March 27, 2024 12:39 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add FSD Pharma Inc (HUGE) Stock to Your Portfolio Wednesday?

FSD Pharma Inc (HUGE) is around the bottom of the Healthcare sector according to InvestorsObserver. HUGE received an overall rating of 21, which means that it scores higher than 21% of stocks. Additionally, FSD Pharma Inc scored a 8 in the Healthcare sector, ranking it higher than 8% of stocks in that sector.

Overall Score - 21
HUGE has an Overall Score of 21. Find out what this means to you and get the rest of the rankings on HUGE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 21 would rank higher than 21 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With FSD Pharma Inc Stock Today?

FSD Pharma Inc (HUGE) stock is trading at $0.71 as of 12:36 PM on Wednesday, Mar 27, an increase of $0.01, or 0.83% from the previous closing price of $0.70. The stock has traded between $0.68 and $0.72 so far today. Volume today is light. So far 92,373 shares have traded compared to average volume of 218,017 shares. Click Here to get the full Stock Report for FSD Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App